News Focus
News Focus
Followers 65
Posts 27751
Boards Moderated 0
Alias Born 11/23/2016

Re: sage4 post# 403845

Saturday, 02/18/2023 8:48:11 PM

Saturday, February 18, 2023 8:48:11 PM

Post# of 517556
Nothing implied I love lecanamab despite the presentation being a complete and thorough example of how these things are done.

My post was in reply to a statement about Anavex comparing Odds Ratios with Lecanamab, where no Odds Ratios were presented.

As an investor I did take a small position in Biogen because it seems clear to me that lecanamab will gain full approval in the US, but possibly not by EMA or Japan.

I may or may not keep that position leading up to the FDA’s second decision on this.

Got it?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News